Jiangsu, China

Jie Chen

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Asieris Pharmaceuticals (Shanghai) Co., Ltd., Jiangsu Electric Power Research Institute, Jiangsu Yahong Meditech Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jie Chen. Retrieved from https://idiyas.com/inventor/jie-chen-wuxuofu0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.7

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jie Chen - Innovator in the Pharmaceutical Industry

Introduction

Jie Chen is a notable inventor based in Taizhou, China. He has made significant contributions to the pharmaceutical industry, particularly through his work with various companies. Despite having no patents to his name, his expertise and experience in the field are commendable.

Latest Patents

Currently, Jie Chen holds 2 patents. This indicates that his innovations may be in the early stages of development or that he has chosen to focus on collaborative projects rather than individual patenting.

Career Highlights

Throughout his career, Jie Chen has worked with reputable companies such as Jiangsu Yahong Meditech Co., Ltd. and Asieris Pharmaceuticals (Shanghai) Co., Ltd. His roles in these organizations have allowed him to contribute to advancements in medical technology and pharmaceuticals.

Collaborations

Jie Chen has collaborated with talented individuals in his field, including Shuai Shen and Haiyan Li. These partnerships have likely enhanced his work and contributed to the development of innovative solutions in the pharmaceutical sector.

Conclusion

Jie Chen is a dedicated inventor whose work in the pharmaceutical industry reflects his commitment to innovation and collaboration. His contributions, although not yet recognized through patents, are valuable to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…